Related Experiment Video
Updated: Mar 13, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Progressive iron deposition and widespread neural dysfunction in Parkinson's disease: a multimodal MRI study
Shuo Liu1, Xinhui Wang2, Wei Wei2
1Department of Medical Imaging, Xinxiang Medical University & Henan Provincial People's Hospital, Zhengzhou, China.
Background:
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms, yet its stage-dependent neurobiological mechanisms remain incompletely understood. Multimodal magnetic resonance imaging (MRI) offers a noninvasive approach to investigate both functional and structural alterations across disease stages. Therefore, this study aimed to characterize stage-dependent functional and iron-related brain alterations in PD using multimodal MRI and to explore their associations with motor severity.
Methods:
We enrolled 104 PD patients, stratified into early-stage (n=49) and advanced-stage (n=55) based on Hoehn and Yahr (H&Y) score, along with 53 age- and sex- matched healthy controls. Quantitative susceptibility mapping (QSM) quantified iron deposition in the substantia nigra (SN) and globus pallidus (GP), while resting-state functional magnetic resonance imaging (rs-fMRI) was used to assess functional alterations using regional homogeneity (ReHo) and fractional amplitude of low-frequency fluctuations (fALFF). Group comparisons were conducted using one-way analysis of variance (ANOVA) with post-hoc tests, and voxel-wise analyses were corrected using cluster-level false discovery rate (FDR, P<0.05). Correlation analyses were performed to evaluate associations between imaging metrics and Unified Parkinson's Disease Rating Scale part III (UPDRS-III) motor scores.
Results:
Compared with healthy controls, both early and advanced-stage PD patients showed significantly increased iron deposition in the bilateral SN and GP (all P<0.05), with higher QSM values in advanced-stage PD than in early-stage PD (all P<0.01). Iron deposition in these regions was positively correlated with motor severity assessed by UPDRS-III scores (all P<0.001). Early-stage PD primarily exhibited abnormal fALFF and ReHo in visual-related regions, whereas advanced-stage PD showed more widespread involvement of the basal ganglia-thalamocortical motor circuit, frontoparietal regions, and limbic structures. Functional alterations in motor-related regions were significantly associated with UPDRS-III scores (all P<0.001), while ReHo changes in limbic regions were correlated with cognitive performance (Mini-Mental State Examination, MMSE; P<0.001).
Conclusions:
Building on established evidence that PD involves progressive iron deposition in the SN and GP and widespread neural network dysfunction, our multimodal MRI findings demonstrate that integrating ReHo, fALFF, and QSM provides a framework for characterizing stage-specific pathophysiological changes and support their potential as biomarkers for early diagnosis, disease staging, and therapeutic development.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...